GLP-1 medications can reduce appetite, slow gastric emptying, and lead to reduced food and fluid intakemaking strategic hydration and mineral intake more important than ever
GLP-1 support, peptide access, and client coaching powered by licensed providers, in 50 states
Available from Accessed 1 Mar 2023 Danne T, Garg S, Peters AL et al (2019) International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors
(2004) Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation
What matters more is technique, site preparation, and rotation
I think